Verfügbarkeit: Characterization of biotechnology pharmaceutical products

Characterization of biotechnology pharmaceutical products: Washington, D. C., USA, December 11 - 13, 1995

Gespeichert in:

Bibliographische Detailangaben
Weitere beteiligte Personen:	Brown, Fred 1925-2004 (HerausgeberIn)
Format:	Buch
Sprache:	Englisch
Veröffentlicht:	Basel [u.a.] Karger 1998
Schriftenreihe:	Developments in biological standardization 96
Schlagwörter:	Proteine Arzneimittel Rekombinantes Protein Biotechnologie Pharmazeutische Technologie Konferenzschrift > 1995 > Washington DC
Umfang:	XI, 207 S.
ISBN:	3805568053

Internformat

MARC


LEADER	00000nam a2200000 cb4500
001	BV024860773
003	DE-604
005	20210702
007	t\|
008	100417s1998 xx \|\|\|\| 00\|\|\| eng d
020			\|a 3805568053 \|9 3-8055-6805-3
035			\|a (OCoLC)883491788
035			\|a (DE-599)BVBBV024860773
040			\|a DE-604 \|b ger \|e rakwb
041	0		\|a eng
049			\|a DE-11
084			\|a VX 5508 \|0 (DE-625)147800:261 \|2 rvk
084			\|a WF 9780 \|0 (DE-625)148466: \|2 rvk
245	1	0	\|a Characterization of biotechnology pharmaceutical products \|b Washington, D. C., USA, December 11 - 13, 1995 \|c proceedings of a symposium organized and sponsored by The Food and Drug Administration, Center for Biologics Evaluation and Research. Vol. ed. Fred Brown ...
264		1	\|a Basel [u.a.] \|b Karger \|c 1998
300			\|a XI, 207 S.
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
490	1		\|a Developments in biological standardization \|v 96
650	0	7	\|a Proteine \|0 (DE-588)4076388-2 \|2 gnd \|9 rswk-swf
650	0	7	\|a Arzneimittel \|0 (DE-588)4003115-9 \|2 gnd \|9 rswk-swf
650	0	7	\|a Rekombinantes Protein \|0 (DE-588)4277353-2 \|2 gnd \|9 rswk-swf
650	0	7	\|a Biotechnologie \|0 (DE-588)4069491-4 \|2 gnd \|9 rswk-swf
650	0	7	\|a Pharmazeutische Technologie \|0 (DE-588)4045699-7 \|2 gnd \|9 rswk-swf
655		7	\|8 1\p \|0 (DE-588)1071861417 \|a Konferenzschrift \|y 1995 \|z Washington DC \|2 gnd-content
689	0	0	\|a Arzneimittel \|0 (DE-588)4003115-9 \|D s
689	0	1	\|a Proteine \|0 (DE-588)4076388-2 \|D s
689	0	2	\|a Biotechnologie \|0 (DE-588)4069491-4 \|D s
689	0		\|8 2\p \|5 DE-604
689	1	0	\|a Rekombinantes Protein \|0 (DE-588)4277353-2 \|D s
689	1	1	\|a Arzneimittel \|0 (DE-588)4003115-9 \|D s
689	1	2	\|a Pharmazeutische Technologie \|0 (DE-588)4045699-7 \|D s
689	1		\|8 3\p \|5 DE-604
700	1		\|a Brown, Fred \|d 1925-2004 \|0 (DE-588)171991923 \|4 edt
710	2		\|a Center for Biologics Evaluation and Research (Bethesda, Md.) \|e Sonstige \|0 (DE-588)2126762-5 \|4 oth
830		0	\|a Developments in biological standardization \|v 96 \|w (DE-604)BV000000884 \|9 96
883	1		\|8 1\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
883	1		\|8 2\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
883	1		\|8 3\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk
943	1		\|a oai:aleph.bib-bvb.de:BVB01-019536145

Datensatz im Suchindex

_version_	1818969230213644288
any_adam_object
author2	Brown, Fred 1925-2004
author2_role	edt
author2_variant	f b fb
author_GND	(DE-588)171991923
author_facet	Brown, Fred 1925-2004
building	Verbundindex
bvnumber	BV024860773
classification_rvk	VX 5508 WF 9780
ctrlnum	(OCoLC)883491788 (DE-599)BVBBV024860773
discipline	Chemie / Pharmazie Biologie
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02343nam a2200517 cb4500</leader><controlfield tag="001">BV024860773</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210702 </controlfield><controlfield tag="007">t\|</controlfield><controlfield tag="008">100417s1998 xx \|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805568053</subfield><subfield code="9">3-8055-6805-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)883491788</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV024860773</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-11</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 5508</subfield><subfield code="0">(DE-625)147800:261</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WF 9780</subfield><subfield code="0">(DE-625)148466:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Characterization of biotechnology pharmaceutical products</subfield><subfield code="b">Washington, D. C., USA, December 11 - 13, 1995</subfield><subfield code="c">proceedings of a symposium organized and sponsored by The Food and Drug Administration, Center for Biologics Evaluation and Research. Vol. ed. Fred Brown ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 207 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Developments in biological standardization</subfield><subfield code="v">96</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Rekombinantes Protein</subfield><subfield code="0">(DE-588)4277353-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1995</subfield><subfield code="z">Washington DC</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Rekombinantes Protein</subfield><subfield code="0">(DE-588)4277353-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brown, Fred</subfield><subfield code="d">1925-2004</subfield><subfield code="0">(DE-588)171991923</subfield><subfield code="4">edt</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Center for Biologics Evaluation and Research (Bethesda, Md.)</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)2126762-5</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Developments in biological standardization</subfield><subfield code="v">96</subfield><subfield code="w">(DE-604)BV000000884</subfield><subfield code="9">96</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-019536145</subfield></datafield></record></collection>
genre	1\p (DE-588)1071861417 Konferenzschrift 1995 Washington DC gnd-content
genre_facet	Konferenzschrift 1995 Washington DC
id	DE-604.BV024860773
illustrated	Not Illustrated
indexdate	2024-12-20T14:17:17Z
institution	BVB
institution_GND	(DE-588)2126762-5
isbn	3805568053
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-019536145
oclc_num	883491788
open_access_boolean
owner	DE-11
owner_facet	DE-11
physical	XI, 207 S.
publishDate	1998
publishDateSearch	1998
publishDateSort	1998
publisher	Karger
record_format	marc
series	Developments in biological standardization
series2	Developments in biological standardization
spelling	Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 proceedings of a symposium organized and sponsored by The Food and Drug Administration, Center for Biologics Evaluation and Research. Vol. ed. Fred Brown ... Basel [u.a.] Karger 1998 XI, 207 S. txt rdacontent n rdamedia nc rdacarrier Developments in biological standardization 96 Proteine (DE-588)4076388-2 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Rekombinantes Protein (DE-588)4277353-2 gnd rswk-swf Biotechnologie (DE-588)4069491-4 gnd rswk-swf Pharmazeutische Technologie (DE-588)4045699-7 gnd rswk-swf 1\p (DE-588)1071861417 Konferenzschrift 1995 Washington DC gnd-content Arzneimittel (DE-588)4003115-9 s Proteine (DE-588)4076388-2 s Biotechnologie (DE-588)4069491-4 s 2\p DE-604 Rekombinantes Protein (DE-588)4277353-2 s Pharmazeutische Technologie (DE-588)4045699-7 s 3\p DE-604 Brown, Fred 1925-2004 (DE-588)171991923 edt Center for Biologics Evaluation and Research (Bethesda, Md.) Sonstige (DE-588)2126762-5 oth Developments in biological standardization 96 (DE-604)BV000000884 96 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk
spellingShingle	Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 Developments in biological standardization Proteine (DE-588)4076388-2 gnd Arzneimittel (DE-588)4003115-9 gnd Rekombinantes Protein (DE-588)4277353-2 gnd Biotechnologie (DE-588)4069491-4 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd
subject_GND	(DE-588)4076388-2 (DE-588)4003115-9 (DE-588)4277353-2 (DE-588)4069491-4 (DE-588)4045699-7 (DE-588)1071861417
title	Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995
title_auth	Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995
title_exact_search	Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995
title_full	Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 proceedings of a symposium organized and sponsored by The Food and Drug Administration, Center for Biologics Evaluation and Research. Vol. ed. Fred Brown ...
title_fullStr	Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 proceedings of a symposium organized and sponsored by The Food and Drug Administration, Center for Biologics Evaluation and Research. Vol. ed. Fred Brown ...
title_full_unstemmed	Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 proceedings of a symposium organized and sponsored by The Food and Drug Administration, Center for Biologics Evaluation and Research. Vol. ed. Fred Brown ...
title_short	Characterization of biotechnology pharmaceutical products
title_sort	characterization of biotechnology pharmaceutical products washington d c usa december 11 13 1995
title_sub	Washington, D. C., USA, December 11 - 13, 1995
topic	Proteine (DE-588)4076388-2 gnd Arzneimittel (DE-588)4003115-9 gnd Rekombinantes Protein (DE-588)4277353-2 gnd Biotechnologie (DE-588)4069491-4 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd
topic_facet	Proteine Arzneimittel Rekombinantes Protein Biotechnologie Pharmazeutische Technologie Konferenzschrift 1995 Washington DC
volume_link	(DE-604)BV000000884
work_keys_str_mv	AT brownfred characterizationofbiotechnologypharmaceuticalproductswashingtondcusadecember11131995 AT centerforbiologicsevaluationandresearchbethesdamd characterizationofbiotechnologypharmaceuticalproductswashingtondcusadecember11131995

Verfügbarkeit

MARC

Datensatz im Suchindex

‌